The British Medical Association (BMA) and GP Committee England (GPCE) have recently voted to support GP collective action which is linked to the negotiation on their contracts with NHS England.
Collective action is different from industrial action but it does mean that some GPs may stop or reduce certain work.
It is unknown how many GP practices will participate in collective action and it is therefore hard to judge the impact this will have on clients across England. However, our ADHD medication clients should be aware that collective action may:
To enter/ remain on the medication pathway, ProblemShared requires you to provide your up-to-date blood pressure, heart rate and weight. In a small number of cases, we may also require an ECG before providing a prescription.
Although the scope of collective action is outside our control, we are working closely with your local NHS and the wider GP community to try and ensure continuity of care where possible.
Your health and wellbeing remain our utmost priority, and we will continue to update this page with alerts and updates.
We continue to experience disruptions in the national supply of ADHD medications.
Given the widespread nature of the shortages, we are unable to start both new and existing clients on certain brands of medication.
In both cases, your prescribing team will explain your options to you and ensure you are fully supported.Below is the current information on medication availability. Please note that this is subject to change, and we will continue to monitor supplies and provide regular updates.
New clients can access our medication service, however, availability of some ADHD medications continues to fluctuate. As one brand goes out of stock there is a huge increase in demand for another, causing a ripple effect.
Currently several Methylphenidate medications (Concerta, Xenidate, Xaggitin) are out of stock from the 3 largest UK pharmaceutical suppliers.
Their teams have informed us that they will receive supply from the manufacturers at some point, but this is all the information they are able to provide.
If you are on an ADHD medication that goes out of stock, your prescribing team will explain your options to you and ensure you feel supported. We continue to monitor supplies and provide our clients with regular updates.
New clients can access our medication service, however, supplies of certain medications remain unstable so we are unable to start both new and existing clients on certain brands of medication.
We continue to monitor supplies and provide our clients with regular updates.
Improved supplies of Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera) - 29/04/24
We have received assurance that stock levels of Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera) are improved, however there is a possibility that this may change in the future.
We continue to monitor supplies and will provide our clients with regular updates. New clients can continue to access our medication service.
New clients can access our medication service, however, supplies of certain medications remain unstable so we are unable to start both new and existing clients on certain brands of medication.
We continue to monitor supplies and provide our clients with regular updates.
The supply of some medications remain unstable as demand fluctuates, and as a result we remain unable to start clients on certain brands of medication.
We continue to monitor supplies and receive regular updates around the types of medication that are currently available.
We will continue to provide our clients with regular updates.
The supply of some Methyphenidate have stabilised so for that reason we have begun to prescribe these medications to new clients.
The supply of Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera) continues to remain uncertain, as a result we will not be prescribing these until supplies stabilise.
As always, we will continue to monitor ongoing supplies and will keep our clients updated during this time.
Long term supplies of certain ADHD medication still remain uncertain and as a responsible healthcare provider, we are following government guidance, which has not changed since the shortage began.
This means that we are still not prescribing medication to any new clients. We are in regular contact with manufacturers and continue to monitor the situation closely.
We will continue to update our clients on a regular basis.
We have contacted each of our clients individually, and discussed the possibility of switching their medication where appropriate.
Long term supplies of Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera) remain uncertain.
As a responsible healthcare provider, we are following government guidance, which has not changed since the shortage began. This means that we are still not prescribing medication to any new clients.
We have received assurance this week that the stock levels of Methyphenidate (Concerta XL, Xenidate XL, Matoride XL, Xaggitin, Equasym XL, Medikinet XL) have stabilised.
Unfortunately, there are still supply issues with Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera).
What does this mean for you or your child?
We are looking to resume prescribing medication as soon as we are able:
There is a global shortage of the following ADHD medications:
As a result, supply reliability is significantly affected. In order to maintain clinical safety, ProblemShared will be advising all clients to take a break from medication. We will not be prescribing ADHD medications until reliable provision of medication can resume.
Please be assured that every effort is being made to find a resolution. While the issue is out of our control, we will do everything we can to support you through this time.
If the medication shortage affects you or your child, you will have received email communication from us advising you on how to proceed with alternative treatment options. For further information, please read the FAQs further down this page, or download our guide to navigating the ADHD medication shortage.
Some suggested coping mechanisms from our clinical team that might help to manage your symptoms during the medication shortage
Download our guideA pre-written letter to take to your employer to inform them of the ADHD medication shortage
Download employer letterA pre-written letter to take to your child’s school to inform them of the ADHD medication shortage
Download school letterIf you’re a client and have any specific questions or concerns, you can email us at: adhdmedication@problemshared.net
Send an emailLisdexamfetamine (Elvanse) & Atomoxetine (Strattera). There is no known end date.
Our counsellors are all members of regulatory bodies and follow best practice guidelines set by those regulatory bodies. Further, we ask them to adhere to a code of conduct drawn from the requirements of professional psychotherapy bodies and National Institute for Health and Care Excellence (NICE) guidelines.
At your next review appointment, your prescriber will discuss with you alternate non-pharmacological options available to you, and help you think about your ongoing treatment. We are monitoring the supply situation daily, and you will receive regular email communication from us. You will be notified as soon as we are able to start prescribing again, and a new appointment will be arranged.We understand that many of you rely on these medications as a crucial part of your treatment, and that this news is likely to be disruptive and distressing. As you may be aware, ADHD medication is robustly regulated, and as a responsible care provider we are currently not prescribing until reliable medication supplies can be achieved. Please be assured that we are doing all we can within this framework to support you in accessing ongoing treatment for your ADHD.
Our counsellors are all members of regulatory bodies and follow best practice guidelines set by those regulatory bodies. Further, we ask them to adhere to a code of conduct drawn from the requirements of professional psychotherapy bodies and National Institute for Health and Care Excellence (NICE) guidelines.
It is common practice for pharmacies to only hold a limited stock of any one type of medication, so we initially had no reason to believe this was to become a broader issue. Supply issues have gradually worsened since mid-August, and now there are severe shortages of multiple dosages of medication.
ADHD pharma companies are currently having challenges with maintaining the required supply of ADHD medication. ADHD services and pharmacies globally are experiencing a significant shortage of all ADHD medications.
The medications with the most impact are:
Lisdexamfetamine (Elvanse) & Atomoxetine (Strattera).
We have been informed by the producers of Lisdexamfetamine that there will be some supply available by mid-November 2023. However, as the global shortage is continuing with no known end date, we will continue not to prescribe ADHD medications until we can be sure that the supply issue has been resolved and that your treatment will not be affected.
ProblemShared have made the difficult decision not to prescribe ADHD medications during this time of medication supply uncertainty, for which we have no known end date.
ProblemShared is aware this decision is likely to be disruptive and distressing for clients. However, ADHD medication is robustly regulated, and as a responsible care provider we are currently not prescribing until reliable medication supplies can be achieved.
We are monitoring the supply situation daily, and in the meantime, our prescribing team are in the process of contacting all clients affected.If your child has a review appointment booked with ProblemShared, this appointment will continue, and your prescriber will discuss with you and your child alternate non-pharmacological options available to you and help you think about your child’s ongoing treatment.
We would additionally advise you to keep your child’s school informed as they may also be able to monitor your child’s behaviour and symptoms in school.
Yes, you will still be able to have an ADHD assessment, and if you receive a positive diagnosis and would like to discuss medication treatment, you will still be able to have a treatment planning session with our prescribing team to discuss your current treatment options. However, please be aware that in accordance with recent government guidelines, we will not be prescribing new clients with medication until the medication supply is rectified.
Treatment planning sessions will continue to go ahead so you can discuss with a prescriber the treatment options that are available to you. However, please be aware that in accordance with recent government guidelines, we will not be prescribing new clients with medication until the medication supply is rectified.
Treatment planning sessions will continue to go ahead so you can discuss with a prescriber the treatment options that are available to you. However, please be aware that in accordance with recent government guidelines, we will not be prescribing new clients with medication until the medication supply is rectified.
You will have received correspondence from ProblemShared regarding our decision not to prescribe any ADHD medications during this time of supply shortage.
ProblemShared is aware this decision is likely to be disruptive and distressing for clients. However, ADHD medication is robustly regulated, and as a responsible care provider we are currently not prescribing until reliable medication supplies can be achieved.
At your next review appointment, your prescriber will discuss with you alternate non-pharmacological options available to you and help you think about your ongoing treatment.
Email enquiries to: adhdmedication@problemshared.net
If you are currently in shared care with your G.P. prescribing for you, or your shared care request gets accepted, your G.P. may decide to keep issuing you with prescriptions. However, if the medication you are on is unavailable, your G.P. will not be able to change you to an alternate medication, and your G.P. will need to seek advice from ProblemShared.
Your G.P. will be informed that we will not be holding any reviews to make alterations to medications until the current stock supply issues are resolved.
ProblemShared is aware this decision is likely to be disruptive and distressing for clients. However, ADHD medication is robustly regulated, and as a responsible care provider we are currently not prescribing until reliable medication supplies can be achieved.